Over the last decade, there has been a growing appreciation of the importance of identifying
and treating cognitive impairment associated with bipolar disorder, since it persists in …

Neurocognitive deficits are evident both in established schizophrenia and bipolar disorder
(BP). However, it has been suggested that schizophrenia, but not BP, is characterized by …

Personalized medicine is rapidly becoming a reality in today's physical medicine. However,
as yet this is largely an aspirational goal in psychiatry, despite significant advances in our …

Objective: Duration of untreated illness represents a potentially modifiable component of any
diagnosis‐treatment pathway. In bipolar disorder (BD), this concept has rarely been …

Objective We discuss the rationale behind staging systems described specifically for bipolar
disorders. Current applications, future directions and research gaps in clinical staging …

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN. Brain glutamate levels
measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta …

Broad neuropsychological deficits have been consistently demonstrated in well-established
bipolar disorder. The aim of the current study was to systematically review …

OBJECTIVE: To provide empirical evidence of the effect of subthreshold symptomatology
(both depressive and manic) on psychosocial functioning, neurocognition and quality of life …

Background During the last decades, there have been many different opinions concerning
the neurocognitive function in Bipolar disorder (BD). The aim of the current study was to …

Dias VV, Balanzá‐Martinez V, Soeiro‐de‐Souza MG, Moreno RA, Figueira ML, Machado‐
Vieira R, Vieta E. Pharmacological approaches in bipolar disorders and the impact on …